Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Nov 30, 2021 12:43pm

95 Views

Post# 34180840

Guy has cried wolf way too many times,opinions mean nothing

All these milestones might mean something to him , but mean nothing to investors, until Tetra has a product approved and that can be marketed he has NOTHING it is all theory and going to be products .Tetra will need approvals and revenue before any of the real pharma companies care, right now they don't care about his dreams and opinions because NOTHING IS APPROVED , they are sitting back and watching Tetra drown and they will make a nothing offer once Guy has spent all of the shareholders money and then make an offer between .15 and .20 cents and he will have no choice to accept because Tetra will be broke, take the offer or fold the company , thats how the big Pharma companies play.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China